Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Concert Pharmaceuticals Inc. (CNCE)

10.99   -0.05 (-0.45%) 05-24 16:00
Open: 11.11 Pre. Close: 11.04
High: 11.165 Low: 10.76
Volume: 74,825 Market Cap: 262M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.186 - 11.241 11.241 - 11.286
Low: 10.609 - 10.683 10.683 - 10.744
Close: 10.885 - 10.999 10.999 - 11.09

Technical analysis

as of: 2019-05-26 10:09:52 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 13.35     One year: 15.59
Support: Support1: 10.06    Support2: 9.21
Resistance: Resistance1: 11.43    Resistance2: 13.35
Pivot: 10.75
Moving Average: MA(5): 10.95     MA(20): 10.62
MA(100): 13.14     MA(250): 14.54
MACD: MACD(12,26): -0.08     Signal(9): -0.24
Stochastic oscillator: %K(14,3): 68.82     %D(3): 71.90
RSI: RSI(14): 51.50
52-week: High: 20.62  Low: 9.21  Change(%): -45.0
Average Vol(K): 3-Month: 31021  10-Days: 14290

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CNCE has closed below upper band by 29.5%. Bollinger Bands are 62.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to CNCE's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 02 May 2019 18:11:03 Z
Concert Pharmaceuticals, Inc. (CNCE) Q1 2019 Earnings Call Transcript

Thu, 25 Apr 2019 17:24:08 Z
Earnings Preview: Concert Pharmaceuticals (CNCE) Q1 Earnings Expected to Decline

Thu, 11 Apr 2019 16:16:47 Z
Concert Pharma Initiates Early-Stage Schizophrenia Study

Mon, 25 Mar 2019 17:12:16 Z
New Strong Sell Stocks for March 25th

Thu, 21 Mar 2019 21:07:48 Z
Noteworthy Thursday Option Activity: FRO, AMTD, CNCE

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 23.80
Shares Float (M) 22.60
% Held by Insiders
% Held by Institutions 91.10
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -2.390
EPS Est. Current Year -2.180
EPS Est. Next Year -2.440
EPS Est. Next Quarter -0.730
Forward EPS -1.751
Book Value (p.s.) 1.750
PEG Ratio
Profit Margin
Operating Margin -7000.10
Return on Assets (ttm) -37.6
Return on Equity (ttm) -43.0
Qtrly Rev. Growth -90.4
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -36.88
Levered Free Cash Flow (M) -17.67

Stock Valuations

P/E -4.60
P/E Growth Ratio
P/BV 6.28
P/S 6539049984.00
P/CF -7.09

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.